Biogen posts Q2 2026 results, sets five late-stage readouts over next four quartersJul 29Quarterly updateBiogenfelzartamab
Biogen Phase 2 felzartamab trial in Graves' disease recruiting since July 2026Jul 23Trial updateBiogenfelzartamab
Sign inSign in